As mentioned above, mtIDH1/2 inhibitors can induce transfusion independence for red blood cells and/or platelets in IDH1/2mt AML patients.28, –30 An interesting observation is that enasidenib can also induce hematopoietic differentiation independently of wtIDH2 or mtIDH2. This evidence concerns the gene IDH1 and acute myeloid leukemia.